ADULT syndrome
Therapeutic area
Dermatology
Rare disease
Yes
- Definition
- ADULT (Acro-dermo-ungual-lacrimal-tooth) syndrome is a rare ectodermal dysplasia syndrome characterized by ectrodactyly, syndactyly, mammary hypoplasia, and excessive freckling as well as other typical ectodermal defects such as hypodontia, lacrimal duct anomalies, hypotrichosis, and onychodysplasia.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- ADULT syndrome
- Therapeutic area
- Dermatology
- ADULT syndrome
- ADULT syndrome
- acro-dermato-ungual-lacrimal-tooth syndrome
- acrodermatounguallacrimaltooth syndrome
- pigment anomaly-ectrodactyly-hypodontia syndrome
- acro dermato ungual lacrimal tooth syndrome
- Severity
- Moderate
- Developmental
- Genetic
- Hereditary
- Syndromic
- Dermatology
- Rheumatology
- MONDO ID
- MONDO:0007072
- Parent condition
- MONDO:0000426
Related records
Broader conditions (24)
- Autosomal dominant disease
- Autosomal genetic disease
- Bone development disease
- Bone disorder
- Congenital limb malformation
- Developmental defect during embryogenesis
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of genetic or genomic mechanism
- Disorder of development or morphogenesis
- Dysostosis
- Ectodermal dysplasia syndrome
- Hereditary disease
- Hereditary epidermal appendage anomaly
- Hereditary skin disorder
- Human disease
- Integumentary system disorder
- Musculoskeletal system disorder
Trials (604)
- 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression
- 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)
- 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
- 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
- 64Cu-GRIP B in Patients With Advanced Malignancies
- 68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors
- 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors
- 89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors
- A Beta-only IL-2 ImmunoTherapY Study
- A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
- A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors
- A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors
- A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
- A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma
- a Feasibility Study of iHD-SRT for BM
- A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
- A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
- A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products